HCA Healthcare Stock-Based Compensation Growth & History (HCA)

HCA Healthcare's stock-based compensation was $401.0M for fiscal 2025.

View full HCA Healthcare company overview

HCA Healthcare annual stock-based compensation history

HCA Healthcare annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31$401.0M$41.0M+11.39%
20242024-12-31$360.0M$98.0M+37.40%
20232023-12-31$262.0M−$79.0M−23.17%
20222022-12-31$341.0M−$99.0M−22.50%
20212021-12-31$440.0M$78.0M+21.55%
20202020-12-31$362.0M$15.0M+4.32%
20192019-12-31$347.0M$79.0M+29.48%
20182018-12-31$268.0M−$2.0M−0.74%
20172017-12-31$270.0M$19.0M+7.57%
20162016-12-31$251.0M$12.0M+5.02%
20152015-12-31$239.0M$76.0M+46.63%
20142014-12-31$163.0M$50.0M+44.25%
20132013-12-31$113.0M$57.0M+101.79%
20122012-12-31$56.0M$30.0M+115.38%
20112011-12-31$26.0M−$6.0M−18.75%
20102010-12-31$32.0M−$8.0M−20.00%
20092009-12-31$40.0M

HCA Healthcare stock-based compensation trends

Over the last five fiscal years, HCA Healthcare's stock-based compensation increased from $362.0M to $401.0M, a change of $39.0M. The latest reported quarter, Q2 2026, shows $85.0M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review HCA Healthcare source filings ↗

Community posts

It’s quiet here.

No posts about HCA yet. Start the conversation.

Write the first post